AJMC April 14, 2021

Brenden O’Hara, RPh, BCACP, is a clinical pharmacist in Provider Engagement Initiatives at Blue Cross Blue Shield of North Carolina.


How can pharmacists improve outcomes in value-based contracts, particularly in the use of specialty therapies?

O’Hara: Lots of different ways. So, what we do in working with our pharmacists is understanding what their day entails and what their work is already doing, and then help support them with data and information and additional views of some of the members that would have that direct desired outcome—direct potential cost of care and different quality improvement outcomes. We share that information with our partners.

Specialty is definitely a big focus. We’re not having many of our chronic disease state medications coming...

Today's Sponsors

Teladoc Health

Today's Sponsors

Canton & Company

Today's Sponsor


Topics: Interview / Q&A, Payment Models, Pharma, Pharma / Biotech, Provider, Trends, Value Based
Payer Launches Value-Based Kidney Care Agreement for CKD, ESKD
Social Risk Adjustment Promotes Health Equity In Value Based Care
Providers call for another chance to sign up for Direct Contracting model
It's time to get health care value assessment right
Pursuing the Holy Grail of Value-Based Care? Penn’s LDI Says Head This Way.